177 related articles for article (PubMed ID: 8909308)
1. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
Fujisawa T; Yamaguchi Y
Cancer; 1996 Nov; 78(9):1892-8. PubMed ID: 8909308
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.
Yamamura Y; Ogura T; Sakatani M; Hirao F; Kishimoto S; Fukuoka M; Takada M; Kawahara M; Furuse K; Kuwahara O
Cancer Res; 1983 Nov; 43(11):5575-9. PubMed ID: 6616485
[TBL] [Abstract][Full Text] [Related]
3. Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative lung cancer patients.
Yasumoto K; Yaita H; Ohta M; Azuma I; Nomoto K; Inokuchi K; Yamamura Y
Cancer Res; 1985 Mar; 45(3):1413-7. PubMed ID: 3155992
[TBL] [Abstract][Full Text] [Related]
4. [Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer].
Yasumoto K; Ichinose Y; Yaita H; Tanaka K; Hara N; Ohta M; Hirota N; Nomoto K; Inokuchi K; Yamamura Y
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):321-7. PubMed ID: 6325864
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
Ogura T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
[TBL] [Abstract][Full Text] [Related]
6. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Fujisawa T; Yamaguchi Y
Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
[TBL] [Abstract][Full Text] [Related]
7. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
Fujisawa T; Yamaguchi Y
Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of non-specific immunotherapy with cell-wall skeleton of Nocardia rubra.
Yasumoto K; Yamamura Y
Biomed Pharmacother; 1984; 38(1):48-54. PubMed ID: 6380607
[TBL] [Abstract][Full Text] [Related]
9. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
[TBL] [Abstract][Full Text] [Related]
11. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
13. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
Kimura H; Yamaguchi Y
Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled study of adjuvant immunotherapy with N-CWS for head and neck malignancies].
Sakai S; Itoh M; Matsunaga T; Yoshida J; Sato T; Miyahara Y; Matsunaga T; Hyoh Y; Ohyama K; Katsuta K
Gan No Rinsho; 1985 Sep; 31(11):1353-61. PubMed ID: 4068237
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of postoperative immunotherapy of gastric cancer].
Ochiai T; Sato H
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):373-9. PubMed ID: 6349536
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
19. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
20. Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.
Khan OA; Fitzgerald JJ; Field ML; Soomro I; Beggs FD; Morgan WE; Duffy JP
Ann Thorac Surg; 2004 Apr; 77(4):1173-8. PubMed ID: 15063229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
